weight loss injection retatrutide Demand for Unapproved Weight-Loss Drug Surges on Social Media drmcgowan was just featured in

This week, lets look at the enduring questions surrounding GLP-1 agonist drugs

Starting in 2018, we allowed respondents who did not know the combined maximum incentive or penalty an employee could receive for health screening and/or wellness and health promotion to answer a categorical question with specified ranges

Microdosing discussions involve both medications, though semaglutide appears more frequently because it has been available longer and is more widely prescribed

When discussing options, clinicians should explore patients prioritieswhether thats weight loss, glucose control, avoiding hypoglycemia, or minimizing medication burden

Companies should examine their promotional statements, social media content, and particularly their websites for potential risks

Weight loss of 515% can improve many obesity-related complications